Scarica l'app Stockscreener
1.08
1.89%
0.02
Dopo l'orario di chiusura:
1.10
0.02
+1.85%
Precedente Chiudi:
$1.06
Aprire:
$1.09
Volume 24 ore:
186.18K
Relative Volume:
0.41
Capitalizzazione di mercato:
$13.96M
Reddito:
$11.41M
Utile/perdita netta:
$-38.92M
Rapporto P/E:
-0.2212
EPS:
-4.8828
Flusso di cassa netto:
$-30.46M
1 W Prestazione:
+18.60%
1M Prestazione:
+18.03%
6M Prestazione:
-34.55%
1 anno Prestazione:
-65.93%
Intervallo 1D:
$1.0444
$1.11
Intervallo di 1 settimana:
$0.9201
$1.11
Portata 52W:
$0.771
$3.4094
Curis Inc Stock (CRIS) Company Profile
Nome
Curis Inc
Settore
Industria
Telefono
617-503-6500
Indirizzo
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.08 | 13.70M | 11.41M | -38.92M | -30.46M | -4.8828 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-19 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-17 | Iniziato | Truist | Buy |
| 2022-04-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2020-07-29 | Iniziato | Laidlaw | Buy |
| 2020-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2016-03-02 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | Reiterato | ROTH Capital | Buy |
| 2015-08-11 | Iniziato | FBR Capital | Outperform |
| 2015-01-22 | Reiterato | Oppenheimer | Outperform |
| 2015-01-21 | Reiterato | ROTH Capital | Buy |
| 2014-05-09 | Reiterato | Oppenheimer | Outperform |
| 2013-10-02 | Iniziato | Robert W. Baird | Outperform |
| 2013-09-30 | Iniziato | Chardan Capital Markets | Buy |
| 2012-11-14 | Iniziato | Stifel Nicolaus | Hold |
| 2012-01-31 | Reiterato | Brean Murray | Buy |
| 2012-01-31 | Reiterato | Summer Street Research | Buy |
| 2011-12-09 | Iniziato | Oppenheimer | Outperform |
| 2011-10-06 | Iniziato | Summer Street Research | Buy |
| 2011-09-22 | Iniziato | MLV Capital | Buy |
| 2011-03-21 | Reiterato | Brean Murray | Buy |
| 2010-02-26 | Reiterato | Roth Capital | Buy |
| 2010-01-07 | Iniziato | Roth Capital | Buy |
Mostra tutto
Curis Inc Borsa (CRIS) Ultime notizie
Support Test: Will Curis Inc benefit from AI trendsTrade Analysis Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target - Yahoo Finance
Curis regains compliance with Nasdaq listing standards, enters monitoring period - Investing.com
Curis Regains Nasdaq Compliance, Remains Under Monitoring Period - TipRanks
Curis (CRIS) targets major share hike to unlock PIPE and new 2026 equity plan - Stock Titan
Curis Advances Clinical Pipeline with Focus on Leukemia Treatments - AD HOC NEWS
Buyout Rumor: Is Curis Inc a potential multi bagger2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Rate Cut: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Curis (CRIS) to Release Earnings on Wednesday - Defense World
Panic Selling: Is Curis Inc exposed to political riskQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Is Curis Inc stock a value trap2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Is Curis Inc. stock a value trapJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch - TipRanks
Bond Watch: Is Curis Inc exposed to political risk2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Curis shares jump after lining up up to $80.8m in private placement financing - MSN
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - marketscreener.com
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset - Yahoo Finance
Curis closes private placement for up to $80.8 million in funding - Investing.com Nigeria
Curis announces closing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Stock Market Recap: Can Curis Inc. stock beat analyst upgradesQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Curis Inc. (CUS0) stock a top dividend aristocrat candidateJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Curis prices private placement of $80.8M - MSN
Volume Recap: Can Curis Inc. stock maintain growth trajectoryEntry Point & Consistent Income Trade Recommendations - ulpravda.ru
Curis (NASDAQ: CRIS) sets PIPE financing with warrants and targets 2027 cash runway - Stock Titan
Curis Announces PIPE Financing and Strategic Capital Strengthening - TipRanks
Curis Signs Multiple Material Agreements - TradingView — Track All Markets
Curis announces $80.8 million private placement to fund drug development By Investing.com - Investing.com Nigeria
Curis Inc: Can This Beaten-Down Cancer Stock Still Surprise The Market? - AD HOC NEWS
Aug Breakouts: Can Curis Inc stock maintain growth trajectoryDividend Hike & Daily Profit Maximizing Trade Tips - moha.gov.vn
Curis, Inc. announced that it expects to receive $20.195 million in funding - marketscreener.com
Curis announces $80.8M private placement - TipRanks
Crude Oil Down 2%; ISM Services PMI Surges In December - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Curis (CRIS) Secures PIPE Deal for Up to $80.8M - GuruFocus
Curis announces pricing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Curis stock soars after securing $80.8 million private placement deal By Investing.com - Investing.com South Africa
Curis stock soars after securing $80.8 million private placement deal - Investing.com India
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PR Newswire
Can Curis Inc stock maintain growth trajectoryWeekly Investment Recap & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Investors Shouldn't Be Surprised By Curis, Inc.'s (NASDAQ:CRIS) 27% Share Price Plunge - simplywall.st
ETF Watch: Will PWV stock outperform global peersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
CUS0 Stock Price and Chart — TRADEGATE:CUS0 - TradingView — Track All Markets
Can Curis Inc. stock attract ESG capital inflowsWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Is Curis Inc. stock a contrarian buyJuly 2025 Selloffs & Safe Entry Point Alerts - Улправда
Will Curis Inc. stock remain a Wall Street favoriteJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - DonanımHaber
Can Curis Inc. stock sustain market leadershipJuly 2025 Recap & Consistent Profit Trade Alerts - Улправда
Alert incorrectly tagged to Curis Inc withdrawn - marketscreener.com
Curis Inc Azioni (CRIS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):